Hong Kong stock anomaly | Hualei Pharmaceutical-B (02552.HK) rose by more than 14%, significant results achieved in company's commercial transformation, sales of Huataiming doubled in the first half of the year.

According to the Wise Finance app, Hualei Medicine-B (02552.HK) rose more than 14%, reaching a high of 4.7 Hong Kong dollars during trading, the highest since February 2023. At the time of writing, it was up 14% at 4.56 Hong Kong dollars, with a turnover of 1.82 billion Hong Kong dollars.